Insider and Congress filingsLive page

Nuwellis, Inc. (NUWE)

Medical - Devices, listed on NASDAQ.

Healthcare25 recent Form 4 transactionsnext earnings Mar 2, 2027

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

EarningsQ3 FY2026 · reported Nov 12, 2026

Nuwellis missed on revenue.

Revenue $2.2M against a $2.5M consensus.

Revenue

Reported$2.2M
Consensus$2.5M

Next report Mar 2, 2027.

Every quarter

Form 4

newest Jun 30, 2026
25

most recent insider transactions on Form 4.

Michael Kendrick McCormickOther · Jun 30, 2026
Gregory D. WallerGrant or award · Apr 28, 2026
Martin J. EmersonGrant or award · Apr 28, 2026

All 25 rows

Companyfrom the company's filings and listing

About Nuwellis, Inc.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical - Devices
Chief executive
Michael McCormick
Employees
38
Listed since
Feb 16, 2012
Market value
-
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$40.06
Dividend yield
-

www.nuwellis.com

Earnings8 reported quarters · next on Mar 2, 2027

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q3 FY2026reported Nov 12, 2026 -$5.81- $2.2M$2.5M EPS n/aRevenue miss
Q2 FY2026reported Aug 13, 2026 -$239.78-$214.20 $2.0M$2.4M EPS missRevenue miss
Q1 FY2026reported May 12, 2026 -$73.08-$315.00 $2.4M$2.1M EPS beatRevenue beat
Q4 FY2025reported Mar 10, 2026 -$52.45- $2.4M$2.3M EPS n/aRevenue beat
Q3 FY2025reported Nov 12, 2025 $19.58- $2.2M$2.5M EPS n/aRevenue miss
Q2 FY2025reported Aug 14, 2025 -$2134.65- $1.7M$2.2M EPS n/aRevenue miss
Q1 FY2025reported May 13, 2025 -$1014.30- $1.9M$2.5M EPS n/aRevenue miss
Q4 FY2024reported Mar 11, 2025 -$138.60-$135.45 $2.3M$2.5M EPS missRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure with an adjusted consensus. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Form 425 most recent Form 4 rows

Insider filings

InsiderTransactionValueSharesDate
Michael Kendrick McCormick Other $00Jun 30, 2026
Gregory D. WallerDirector Grant or award $8K6,744Apr 28, 2026
Martin J. EmersonDirector Grant or award $8K6,744Apr 28, 2026
Archelle Georgiou FeldshonDirector Grant or award $8K6,744Apr 28, 2026
David McDonaldDirector Grant or award $8K6,744Apr 28, 2026
Martin J. Emerson Other $00Feb 24, 2026
David McDonaldDirector Other $00Feb 24, 2026
David McDonaldDirector Other $00Feb 24, 2026
Carisa Schultz Other $00Jan 28, 2026
Katharyn Field Other $00Jan 21, 2026
Mika Grasso Other $00Jan 21, 2026
John L. ErbCEO and President Grant or award $27K115,329Jun 27, 2025
John L. ErbCEO and President Debt conversion $4517,522Jun 10, 2025
John L. ErbCEO and President Debt conversion $66K1,092,500Jun 9, 2025
John L. ErbCEO and President Other transaction $6100Jun 9, 2025
John L. ErbCEO and President Debt conversion $466Jun 9, 2025
John L. ErbCEO and President Other transaction $6100Jun 9, 2025
David McDonaldDirector Grant or award $17K17,496May 20, 2025
Michael Kendrick McCormickDirector Grant or award $17K17,496May 20, 2025
Archelle Georgiou FeldshonDirector Grant or award $17K17,496May 20, 2025
Gregory D. WallerDirector Grant or award $17K17,496May 20, 2025
Michael Kendrick McCormickDirector Grant or award $14K20,836Jan 2, 2024
David McDonaldDirector Grant or award $8K11,365Jan 2, 2024
Archelle Georgiou FeldshonDirector Grant or award $8K11,365Jan 2, 2024
David McDonald Other $00Nov 1, 2023

Open-market purchases and sales are decisions; awards, exercises, gifts and shares withheld for tax file on the same form and are labelled for what they are. How the filing works is explained in our guide to Form 4.

STOCK Actnone on record

Congress trades in NUWE

No member of Congress has disclosed a trade in this stock in the period we hold.

13F filingsnone on record

Institutional holders

No 13F holder on record.

Built on request from the same sources as the app, and cached for an hour. A company with enough filings earns a permanent page in the build.

Follow NUWE in the app for a push the moment its next filing lands. Methodology. Nothing here is investment advice.